TWI736855B - Use of passiflora flower extracts for enhancing mitochondrial activity and anti-aging gene expression in skin cells - Google Patents
Use of passiflora flower extracts for enhancing mitochondrial activity and anti-aging gene expression in skin cells Download PDFInfo
- Publication number
- TWI736855B TWI736855B TW108107295A TW108107295A TWI736855B TW I736855 B TWI736855 B TW I736855B TW 108107295 A TW108107295 A TW 108107295A TW 108107295 A TW108107295 A TW 108107295A TW I736855 B TWI736855 B TW I736855B
- Authority
- TW
- Taiwan
- Prior art keywords
- passiflora
- extract
- aging
- cells
- flower
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本發明係關於一種西番蓮花萃取物的保健用途,特別係關於一種西番蓮花萃取物用於製備促進皮膚細胞粒線體活性或抗老化基因表現之組合物之用途。 The present invention relates to the health care use of a passionflower extract, in particular to the use of a passionflower extract to prepare a composition that promotes the mitochondrial activity of skin cells or the expression of anti-aging genes.
隨著人口平均年齡的延長,擁有健康而高品質的老年生活成為大眾關注的焦點之一,關於老化的科學研究也越發受重視。老化可大致定義為生理機能隨時間而衰退,其與許多流行疾病相關,例如心血管疾病、癌症、代謝疾病、神經退化疾病等。老化的過程複雜而受到諸多因素影響,包括飲食、運動、心理狀態、及遺傳因子。在分子或細胞層次,可能的內部機制包括染色體末端的端粒(telomere)縮短、基因突變、基因表現失調、蛋白質恆定喪失、粒線體功能下降等。此外,細胞周圍環境中由物理或化學因素產生的自由基(如活性氧物質)會損害細胞的染色體去氧核醣核酸(DNA)、蛋白質、及脂質生物膜,因而破壞細胞的機能。 With the increase in the average age of the population, having a healthy and high-quality elderly life has become one of the focuses of public attention, and scientific research on aging has also become more and more important. Aging can be roughly defined as the decline of physiological functions over time, which is associated with many epidemic diseases, such as cardiovascular diseases, cancer, metabolic diseases, neurodegenerative diseases and so on. The aging process is complicated and affected by many factors, including diet, exercise, mental state, and genetic factors. At the molecular or cellular level, possible internal mechanisms include shortening of telomeres at the ends of chromosomes, gene mutations, dysregulation of gene expression, constant loss of protein, and decreased mitochondrial function. In addition, free radicals (such as reactive oxygen species) generated by physical or chemical factors in the surrounding environment of the cell can damage the chromosomal DNA, protein, and lipid biofilms of the cell, thereby destroying the function of the cell.
鑒於上述造成老化的因素複雜,延緩身體乃至於各種細胞老化可以從多方面著手,包括改變飲食與運動習慣、保持心情愉快、減少暴露於誘導自由基形成的環境因子(如紫外光)、及加強細胞保護機制的運作(例如促進抗老化基因之表現)。其中,促進細胞保護機制的方法正處於發展階段,究竟何種手段能加強細胞保護機制尚在研究當中。因此,開發一種能促進細胞保護機制的新穎組合物,為減緩細胞機能衰退與維持細胞健康狀態提供新方向,實有其必要。 In view of the complexity of the above-mentioned factors that cause aging, delaying the aging of the body and even various cells can be done in many ways, including changing diet and exercise habits, maintaining a happy mood, reducing exposure to environmental factors that induce the formation of free radicals (such as ultraviolet light), and strengthening The operation of cell protection mechanisms (such as promoting the expression of anti-aging genes). Among them, the methods to promote cell protection mechanisms are in the development stage, and what kind of methods can strengthen the cell protection mechanisms is still under study. Therefore, it is really necessary to develop a novel composition that can promote cell protection mechanisms and provide a new direction for slowing the decline of cell function and maintaining cell health.
緣此,本發明之一目的在提供一種西番蓮(Passiflora spp.)花萃取物用於製備促進皮膚細胞粒線體活性之組合物之用途,其中該西番蓮花萃取物係以一溶劑萃取一西番蓮花而獲得。 For this reason, one object of the present invention is to provide a use of a Passiflora (Passiflora spp.) flower extract for preparing a composition for promoting mitochondrial activity of skin cells, wherein the Passiflora spp. is extracted with a solvent Obtained from a passiflora flower.
在本發明之一實施例中,該西番蓮花萃取物係以水、醇類、或醇水混合物為溶劑而萃取。 In an embodiment of the present invention, the passionflower extract is extracted with water, alcohols, or a mixture of alcohol and water as a solvent.
在本發明之一實施例中,該西番蓮花萃取物抑制一聚二磷酸腺苷核糖聚合酶(亦稱聚ADP核糖聚合酶,poly(ADP-ribose)polymerase,PARP)之基因表現,且該聚二磷酸腺苷核糖聚合酶包含聚二磷酸腺苷核糖聚合酶1(PARP1)及聚二磷酸腺苷核糖聚合酶2(PARP2)。已知PARP與粒線體機能失調相關,故西番蓮花萃取物可能但不限於藉由對PARP基因表現的抑制作用達到提升粒線體活性之效果。 In one embodiment of the present invention, the passionflower extract inhibits the gene expression of adenosine monophosphate ribose polymerase (also known as poly(ADP-ribose) polymerase, PARP), and the Adenosine polyphosphate ribose polymerase includes polyadenosine diphosphate ribose polymerase 1 (PARP1) and polyadenosine diphosphate ribose polymerase 2 (PARP2). It is known that PARP is related to mitochondrial dysfunction, so Passiflora extract may, but is not limited to, achieve the effect of enhancing mitochondrial activity by inhibiting PARP gene expression.
本發明之另一目的在提供一種西番蓮花萃取物用於製備促進皮膚細胞抗老化基因表現之組合物之用途,其中該西番蓮花萃取物係以一溶劑萃取一西番蓮花而獲得。 Another object of the present invention is to provide a use of a passionflower extract for preparing a composition for promoting anti-aging gene expression of skin cells, wherein the passionflower extract is obtained by extracting a passionflower flower with a solvent.
在本發明之一實施例中,該抗老化基因編碼一自噬相關蛋白(autophagy-related protein,ATG),包含自噬相關蛋白1(ATG1)及自噬相關蛋白8(ATG8)。 In an embodiment of the present invention, the anti-aging gene encodes an autophagy-related protein (ATG), including autophagy-related protein 1 (ATG1) and autophagy-related protein 8 (ATG8).
在本發明之一實施例中,該抗老化基因編碼一磷酸酶及張力蛋白同源物誘導激酶1(phosphatase and tensin homolog(PTEN)-induced putative kinase 1,PINK1)。 In one embodiment of the present invention, the anti-aging gene encodes a phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1).
在本發明之一實施例中,該抗老化基因編碼一沉默信息調節因子2同源蛋白1(silent mating type information regulation 2 homolog 1或sirtuin 1,SIRT1)或一叉頭框蛋白O3(forkhead box class O 3,FOXO3)。
In an embodiment of the present invention, the anti-aging gene encodes a silent mating
在本發明之一實施例中,該抗老化基因係編碼一端粒酶反轉錄酶(telomerase reverse transcriptase,TERT)、一端粒酶核醣核酸組分(telomerase RNA component,TERC)、或其組合。因此,該西番蓮花萃取物能促進皮膚細胞內端粒酶之合成。 In an embodiment of the present invention, the anti-aging gene encodes telomerase reverse transcriptase (TERT), telomerase RNA component (TERC), or a combination thereof. Therefore, the passion flower extract can promote the synthesis of telomerase in skin cells.
在本發明之一實施例中,用於促進皮膚細胞粒線體活性或抗老化基因表現之西番蓮花萃取物之濃度為0.125mg/mL至0.25mg/mL。 In an embodiment of the present invention, the concentration of the Passiflora extract used to promote the mitochondrial activity of skin cells or the expression of anti-aging genes is 0.125 mg/mL to 0.25 mg/mL.
本發明基於體外細胞實驗及基因表現分析結果,揭示西番蓮花萃取物提升皮膚細胞粒線體活性以及多種抗老化基因之表現。鑒於粒線體活性之維持對細胞活力極為重要,且前述抗老化基因涉及老化粒線體更新、細胞壓力反應(即協助逆境中細胞減少損傷的多種分子機制)、及端粒延長等有利細胞回春之事件,西番蓮花萃取物具備維持皮膚細胞活力及個體皮膚年輕狀態之潛力。因此,本發明提供西番蓮花萃取物用於製備促進皮膚細胞粒線體活性或抗老化基因表現之組合物之用途。該組合物可為粉末狀、顆粒狀、液狀、膠狀或膏狀,且可製成食品、飲品、藥品、試劑或營養補充劑,藉由口服、皮膚塗抹等方式給予一個體。 Based on the results of in vitro cell experiments and gene expression analysis, the present invention reveals that Passiflora extract enhances the mitochondrial activity of skin cells and the performance of a variety of anti-aging genes. In view of the fact that the maintenance of mitochondrial activity is extremely important for cell viability, and the aforementioned anti-aging genes are involved in aging mitochondrial renewal, cellular stress response (that is, a variety of molecular mechanisms that help cells reduce damage in adversity), and telomere extension and other beneficial cell rejuvenation In the event, passion flower extract has the potential to maintain the vitality of skin cells and the youthful state of the individual's skin. Therefore, the present invention provides the use of Passiflora extract for preparing a composition that promotes mitochondrial activity of skin cells or anti-aging gene expression. The composition can be in the form of powder, granules, liquid, gel or paste, and can be made into food, drink, medicine, reagent or nutritional supplement, and administered to a body by oral administration, skin application and other methods.
以下將配合圖式進一步說明本發明的實施方式,下述所列舉的實施例係用以闡明本發明之發明特點及應用,而非以限定本發明之範圍,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可做些許更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 The following will further illustrate the embodiments of the present invention in conjunction with the drawings. The following examples are used to illustrate the inventive features and applications of the present invention, rather than to limit the scope of the present invention. Anyone familiar with the art will not depart from Within the spirit and scope of the present invention, some changes and modifications can be made. Therefore, the protection scope of the present invention shall be subject to those defined by the appended patent scope.
圖1顯示人類皮膚纖維母細胞在有或無西番蓮花萃取物處理24小時後,細胞中JC-1聚集體的相對量(%)。 Figure 1 shows the relative amount (%) of JC-1 aggregates in human skin fibroblasts treated with or without Passiflora extract for 24 hours.
圖2顯示人類皮膚纖維母細胞在有或無西番蓮花萃取物處理48小時後,相對於控制組細胞的PARP1與PARP2基因的相對表現量。 Figure 2 shows the relative expression levels of PARP1 and PARP2 genes of human skin fibroblasts after 48 hours of treatment with or without Passiflora extract, relative to the control group cells.
圖3顯示人類皮膚纖維母細胞在有或無西番蓮花萃取物處理48小時後,相對於控制組細胞的PINK1、ATG1,ATG8、SIRT1、FOXO3、TERT、及TERC基因的相對表現量。 Figure 3 shows the relative expression levels of PINK1, ATG1 , ATG8, SIRT1, FOXO3, TERT , and TERC genes of human skin fibroblasts treated with or without Passiflora extract for 48 hours relative to control cells.
本發明提供一種西番蓮花萃取物用於製備促進皮膚細胞粒線體活性或抗老化基因表現之組合物之用途。本發明之西番蓮花萃取物係以一溶劑萃取一西番蓮花而獲得,其中,該溶劑可為水、醇類、或醇水混合物,較佳為水。下列實施例顯示該西番蓮花萃取物之處理能提升人類皮膚細胞之粒線體活性,並且抑制與粒線體機能失調有關之多種聚ADP核糖聚合酶(PARP;例如PARP1及PARP2)之基因表現。此外,該西番蓮花萃取物促進人類皮膚細胞中抗
老化基因之表現。前述抗老化基因表現之產物可為核糖核酸(RNA)或蛋白質,包括但不限於:磷酸酶及張力蛋白同源物誘導激酶1(PINK1)、多種自噬相關蛋白(ATG;例如ATG1及ATG8)、沉默信息調節因子2同源蛋白1(SIRT1)、叉頭框蛋白O3(FOXO3)、及參與端粒酶反應的端粒酶反轉錄酶(TERT)及端粒酶RNA組分(TERC)。
The present invention provides a use of Passiflora extract for preparing a composition for promoting mitochondrial activity of skin cells or anti-aging gene expression. The Passiflora extract of the present invention is obtained by extracting a Passiflora flower with a solvent, wherein the solvent can be water, alcohol, or a mixture of alcohol and water, preferably water. The following examples show that the treatment of the passionflower extract can enhance the mitochondrial activity of human skin cells and inhibit the gene expression of various poly ADP ribose polymerases (PARP; such as PARP1 and PARP2) related to mitochondrial dysfunction . In addition, the passion flower extract promotes anti-inflammatory effects in human skin cells.
The performance of aging genes. The product of the aforementioned anti-aging gene expression can be ribonucleic acid (RNA) or protein, including but not limited to: phosphatase and tensin homologue inducing kinase 1 (PINK1), various autophagy-related proteins (ATG; such as ATG1 and ATG8) ,
本文中所使用數值為近似值,所有實驗數據皆表示在20%的範圍內,較佳為在10%的範圍內,最佳為在5%的範圍內。 The numerical values used herein are approximate values, and all experimental data are expressed in the range of 20%, preferably in the range of 10%, and most preferably in the range of 5%.
本文中所謂「粒線體活性」指粒線體運作的效力,包括能量產生、物質代謝、活性氧物質清除效率等。粒線體活性之評估可依據本發明所屬技術領域所習知之生化、分子生物及細胞學技術而完成,例如本文所述粒線體膜電位之測定。 The so-called "mitochondrial activity" in this article refers to the effectiveness of mitochondrial operations, including energy production, material metabolism, and the removal efficiency of reactive oxygen species. The assessment of mitochondrial activity can be accomplished according to the biochemical, molecular biology and cytological techniques known in the technical field of the present invention, such as the measurement of mitochondrial membrane potential described herein.
本文中所謂「抗老化基因」泛指其存在與生物體長壽相關或其RNA或蛋白質產物之作用可維持細胞正常功能的基因。該抗老化基因所編碼蛋白質之作用包括促使粒線體正常運作、協助其他蛋白質摺疊、促進端粒酶合成、及調控參與養分代謝或細胞壓力反應之蛋白質的基因表現等。 The "anti-aging genes" used herein generally refer to genes whose existence is related to the longevity of organisms or whose RNA or protein products can maintain normal cell function. The functions of the protein encoded by the anti-aging gene include promoting the normal operation of mitochondria, assisting in the folding of other proteins, promoting the synthesis of telomerase, and regulating the gene expression of proteins involved in nutrient metabolism or cellular stress response.
含有Earle’s平衡鹽溶液(Earle’s balanced salt solution,EBSS)之Eagle’s最低基本培養基(Gibco Eagle’s minimum essential medium,MEM)、胎牛血清(Gibco fetal bovine serum,FBS)、丙酮酸鈉、青黴素/鏈黴素(penicillin/streptomycin)、及磷酸緩衝鹽溶液(Gibco phosphate buffered saline,PBS)係購自Thermo Fischer Scientific公司。 Gibco Eagle's minimum essential medium (MEM), Gibco fetal bovine serum (FBS), sodium pyruvate, penicillin/streptomycin (Gibco Eagle's minimum essential medium, FBS) containing Earle's balanced salt solution (EBSS) Penicillin/streptomycin) and phosphate buffered saline (Gibco phosphate buffered saline, PBS) were purchased from Thermo Fischer Scientific.
以下實施例使用購自食品工業發展研究所生物資源保存及研究中心(Bioresource Collection and Research Center,BCRC)之人類皮膚纖維母細胞(human skin fibroblast)CCD-966SK(BCRC 60153)。CCD-966SK細胞在37℃、5%二氧化碳的條件下培養於MEM培養基(含有EBSS),該培養基並添加10%胎牛血 清、1mM丙酮酸鈉、0.01M非必需胺基酸、及1%青黴素-鏈黴素,以下稱MEM細胞培養基。 The following examples used human skin fibroblast CCD-966SK (BCRC 60153) purchased from the Bioresource Collection and Research Center (BCRC) of the Food Industry Development Institute. CCD-966SK cells are cultured in MEM medium (containing EBSS) at 37°C and 5% carbon dioxide, which is supplemented with 10% fetal bovine blood Clear, 1mM sodium pyruvate, 0.01M non-essential amino acid, and 1% penicillin-streptomycin, hereinafter referred to as MEM cell culture medium.
本文中所謂西番蓮花萃取物係以一溶劑對一西番蓮屬(Passiflora spp.)植物的花(簡稱西番蓮花,例如百香果(Passiflora edulis)、毛西番蓮(Passiflora foetida)的花)進行萃取而獲得。該溶劑可為水、醇類、或醇水混合物,較佳為水。在一實施例中,進行萃取前先洗淨及乾燥西番蓮花,使用均質機將其粗碎。其後,以攪拌方式均勻混合該溶劑與該西番蓮花均質物0.5至3小時即可製得西番蓮花萃取物;該溶劑與該西番蓮花均質物的重量比範圍為20:1至2:1,較佳為5:1;萃取溫度為40℃至75℃。以下實施例所用西番蓮花萃取物係購自陝西嘉禾生物科技股份有限公司,其依類似前述步驟製備而得。 Herein called passion flower extract with a solvent-based plant Passiflora a flower (Passiflora spp.) (Referred to as passion flower, for example, passion fruit (Passiflora edulis), Passiflora foetida (Passiflora foetida) Flowers ) Is obtained by extraction. The solvent may be water, alcohols, or a mixture of alcohol and water, preferably water. In one embodiment, the passiflora flower is washed and dried before extraction, and then coarsely crushed using a homogenizer. Thereafter, the solvent and the homogenous passiflora flower are uniformly mixed in a stirring manner for 0.5 to 3 hours to obtain a passiflora extract; the weight ratio of the solvent to the homogenous passiflora flower is in the range of 20:1 to 2 :1, preferably 5:1; extraction temperature is 40°C to 75°C. The Passiflora extract used in the following examples was purchased from Shaanxi Jiahe Biotechnology Co., Ltd., and was prepared in a similar manner to the foregoing steps.
為評估細胞的粒線體活性,利用流式細胞儀(flow cytometer;Beckman Coulter Life Sciences)及粒線體膜電位檢測套組(BDTM MitoScreen)測定粒線體膜電位之改變,其步驟簡述如下。依據廠商使用說明,以PBS溶液潤洗待測細胞,再將細胞收集至1.5mL微量離心管及進行離心(400 xg,5分鐘)。經移除上清液,以PBS溶液再懸浮細胞並且再次離心(400 xg,5分鐘)。將100μL JC-1(5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide)操作溶液與沉澱之細胞在暗處均勻混合15分鐘以進行螢光標記,再以清洗溶液及離心步驟(400 xg,5分鐘)清洗細胞2次。最終,將細胞再懸浮於含2% FBS之PBS溶液,使用流式細胞儀偵測指示粒線體膜電位的JC-1聚集體的相對量(激發波長為約490nm,偵測波長為約595nm)。JC-1聚集體的量越多表示粒線體內膜的電位差越大,被視為粒線體活性越高。 In order to evaluate the mitochondrial activity of cells, flow cytometer (Beckman Coulter Life Sciences) and mitochondrial membrane potential detection kit (BD TM MitoScreen) were used to measure the changes in mitochondrial membrane potential. The steps are briefly described. as follows. According to the manufacturer's instructions, rinse the cells to be tested with PBS solution, then collect the cells into a 1.5 mL microcentrifuge tube and centrifuge (400 xg, 5 minutes). After removing the supernatant, the cells were resuspended in a PBS solution and centrifuged again (400 xg, 5 minutes). Mix 100μL of JC-1 (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide) operating solution with the precipitated cells in the dark for 15 minutes for fluorescent labeling. Wash the cells twice with washing solution and centrifugation step (400 xg, 5 minutes). Finally, the cells were resuspended in a PBS solution containing 2% FBS, and a flow cytometer was used to detect the relative amount of JC-1 aggregates indicating the mitochondrial membrane potential (excitation wavelength is about 490nm, detection wavelength is about 595nm ). The greater the amount of JC-1 aggregates, the greater the potential difference in the inner mitochondrial membrane, which is regarded as the higher the mitochondrial activity.
基於定量聚合酶鏈鎖反應(quantitative polymerase chain reaction,簡稱qPCR)測定細胞中有關粒腺體活性與抗老化之基因表現,其步驟簡述如下。依據廠商使用說明,利用RNA萃取套組(RNA Extraction Kit;Geneaid)自細胞分離出RNA,於37℃下以反轉錄酶SuperScript® III Reverse Transcriptase(Invitrogen)將2000ng RNA反轉錄為cDNA。其次,利用qPCR套組(KAPA CYBRFAST qPCR Kit(2X);KAPA Biosystems)以及下表1所列目標基因與作為內部對照之甘油醛3- 磷酸脫氫酶(Glyceraldehyde 3-phosphate dehydrogenase,GAPDH)基因之引子對在PCR反應儀(Step One Plus Real-Time PCR system;Applied Biosystems)對前述cDNA進行qpCR,以取得解鏈曲線(melting curve)。 Based on the quantitative polymerase chain reaction (qPCR) to determine the mitochondrial activity and anti-aging gene expression in cells, the steps are briefly described as follows. According to the manufacturer’s instructions, RNA was isolated from cells using RNA Extraction Kit (Geneaid), and 2000ng of RNA was reverse-transcribed into cDNA with SuperScript® III Reverse Transcriptase (Invitrogen) at 37°C. Secondly, use the qPCR kit (KAPA CYBRFAST qPCR Kit (2X); KAPA Biosystems) and the target genes listed in Table 1 below and the glyceraldehyde 3- The primer pair of phosphate dehydrogenase (Glyceraldehyde 3-phosphate dehydrogenase, GAPDH) gene is qpCR performed on the aforementioned cDNA in a PCR reaction machine (Step One Plus Real-Time PCR system; Applied Biosystems) to obtain a melting curve.
最終,使用2-△△CT方法測定目標基因的相對表現量。該方法以GAPDH基因的循環閾值(CT)作為內部對照之參考基因的循環閾值,按照以下公式計算相對倍數變化:△CT=實驗組或控制組的目標基因的CT-內部對照的CT Finally, use the 2- △△CT method to determine the relative expression of the target gene. The method is the threshold cycle (C T) GAPDH gene as an internal control of the reference cycle threshold gene, calculated by the following formula relative fold change: C gene of △ C T = the experimental group or the control group T - internal control C T
△△CT=實驗組的△CT-控制組的△CT △△ C T = test group △ C T - △ C T of the control group
倍數變化=2-△△Ct平均值 Multiple change=2 -△△Ct average value
統計分析係使用Excel軟體中的STDEV函數計算各基因相對表現量的標準差,並以單尾學生T檢驗(TTEST)計算統計上差異。 The statistical analysis department uses the STDEV function in Excel software to calculate the standard deviation of the relative expression of each gene, and uses the one-tailed Student’s T test (TTEST) to calculate the statistical difference.
粒線體是供給細胞能量的胞器,並且參與細胞的氧化還原恆定及養分代謝,其正常運作對維持細胞的活力與增殖能力至關重要。為探討西番蓮花萃取物對皮膚細胞粒線體功能的影響,本實施例以流式細胞儀評估人類皮膚纖維母細胞CCD-966SK經西番蓮花萃取物處理後,其粒線體活性的變化。首先,將CCD-966SK細胞依1×105個細胞/孔接種於6孔盤,各孔含有2mL MEM細胞培養基。在37℃培養細胞24小時後,移除該細胞培養基,並以1mL含0.125mg/mL西番蓮花萃取物之MEM細胞培養基處理細胞(實驗組),或者僅用MEM細胞培養基處理細胞以作為控制組。各組細胞於37℃培養24小時後用於粒線體活性分析,以螢光染劑JC-1指示粒線體膜電位及活性。 Mitochondria are organelles that supply cell energy and participate in cell redox constant and nutrient metabolism. Their normal operation is essential to maintain cell viability and proliferation. In order to explore the influence of passion flower extract on mitochondrial function of skin cells, this example uses flow cytometry to evaluate the changes in mitochondrial activity of human skin fibroblasts CCD-966SK after treatment with passion flower extract . First, CCD-966SK cells were seeded in a 6-well plate at 1×10 5 cells/well, and each well contained 2 mL of MEM cell culture medium. After culturing the cells at 37°C for 24 hours, remove the cell culture medium and treat the cells with 1 mL of MEM cell culture medium containing 0.125 mg/mL Passiflora extract (experimental group), or treat the cells only with MEM cell culture medium as a control Group. The cells of each group were cultured at 37°C for 24 hours and then used for mitochondrial activity analysis. The fluorescent dye JC-1 was used to indicate the mitochondrial membrane potential and activity.
圖1顯示前述各組CCD-966SK細胞中JC-1聚集體的相對量(%),其值越高表示細胞的平均粒線體活性越高;***表示相比控制組為p<0.001。依據圖1,相比控制組細胞,施予0.125%西番蓮花萃取物顯著提高CCD-966SK細胞的JC-1聚集體相對量約40%,說明西番蓮花萃取物能提升皮膚細胞粒線體活性,使皮膚細胞有足夠活力執行特定生理功能或增殖以汰換老舊細胞。因此,西番蓮花萃取物有利於維持人類個體皮膚的年輕狀態。 Figure 1 shows the relative amount (%) of JC-1 aggregates in the aforementioned groups of CCD-966SK cells. The higher the value, the higher the average mitochondrial activity of the cells; *** means p<0.001 compared to the control group . According to Figure 1, compared with the control group, the administration of 0.125% Passiflora extract significantly increased the relative amount of JC-1 aggregates of CCD-966SK cells by about 40%, indicating that Passiflora extract can enhance the mitochondria of skin cells Activity, so that skin cells have enough vitality to perform specific physiological functions or proliferate to replace old cells. Therefore, Passiflora extract is beneficial to maintain the youthful state of individual human skin.
為探討西番蓮花萃取物對皮膚細胞抗老化力的影響,利用qPCR測定人類皮膚纖維母細胞CCD-966SK經西番蓮花萃取物處理後,其聚ADP核糖聚合酶1及2(PARP1及PARP2)、磷酸酶及張力蛋白同源物誘導激酶1(PINK1)、自嗜相關蛋白1及8(ATG1及ATG8)、沉默信息調節因子2同源蛋白1(SIRT1)、叉頭框蛋白O3(FOXO3)、端粒酶反轉錄酶(TERT)、及端粒酶RNA組分(TERC)之基因表現變化。簡言之,將CCD-966SK細胞依1.5×105個細胞/孔接種於6孔盤,各孔含有2mL MEM細胞培養基。在37℃培養細胞24小時後,移除該細胞培養基,並以1mL含0.125mg/mL或0.25mg/mL西番蓮花萃取物之MEM細胞培養基處理細
胞(實驗組),或者僅以MEM細胞培養基處理細胞以作為控制組。前述細胞於37℃培養48小時後用於qPCR分析。
In order to explore the influence of passion flower extract on the anti-aging ability of skin cells, qPCR was used to determine the poly
圖2顯示CCD-966SK細胞以0.125mg/mL西番蓮花萃取物處理48小時後相對於控制組細胞的PARP1與PARP2基因的相對表現量。依據圖2,西番蓮花萃取物之處理會抑制CCD-966SK細胞中多種聚ADP核糖聚合酶(PARP)之基因表現。鑒於先前研究指出該種酵素活性之抑制可改善粒線體活性,此結果暗示西番蓮花萃取物能增加粒線體活性,進而改善細胞的能量產生及對抗老化。 Figure 2 shows the relative expression levels of PARP1 and PARP2 genes of CCD-966SK cells treated with 0.125mg/mL Passiflora extract for 48 hours relative to control group cells. According to Figure 2, the treatment of Passiflora extract inhibits the gene expression of multiple poly ADP ribose polymerase (PARP) in CCD-966SK cells. In view of previous studies that the inhibition of this enzyme activity can improve mitochondrial activity, this result suggests that Passiflora extract can increase mitochondrial activity, thereby improving cell energy production and combating aging.
圖3顯示CCD-966SK細胞以0.25mg/mL西番蓮花萃取物處理48小時後相對於控制組細胞的PINK1、ATG1,ATG8、SIRT1、FOXO3、TERT、及TERC基因的相對表現量;*、**、及***分別表示相比控制組為p<0.05、p<0.01、及p<0.001。依據圖3,相比控制組,對CCD-966SK細胞施予西番蓮花萃取物顯著提高與老化粒線體更新相關之PINK1、ATG1、及ATG8基因之表現,並且促進與細胞壓力反應相關之SIRT1及FOXO3基因之表現。此外,西番蓮花萃取物亦提升參與端粒酶反應以延長端粒之TERT及TERC基因之表現。此結果說明西番蓮花萃取物提高皮膚細胞中多種抗老化基因之產物,因此有助於維持皮膚細胞的活力及延緩肌膚老化。 Figure 3 shows the relative expression levels of PINK1, ATG1, ATG8, SIRT1, FOXO3, TERT , and TERC genes of CCD-966SK cells treated with 0.25mg/mL Passiflora extract for 48 hours relative to control group cells ; * , * * , and *** indicate p<0.05, p<0.01, and p<0.001 compared to the control group, respectively. According to Figure 3, compared with the control group, administration of Passiflora extract to CCD-966SK cells significantly improved the expression of PINK1, ATG1 , and ATG8 genes related to aging mitochondrial turnover, and promoted SIRT1, which is related to cellular stress response. And the performance of FOXO3 gene. In addition, Passiflora extract also enhances the expression of TERT and TERC genes involved in the telomerase reaction to prolong telomeres. This result shows that the extract of Passionflower flower enhances the products of various anti-aging genes in skin cells, thereby helping to maintain the vitality of skin cells and delay skin aging.
綜上所述,西番蓮花萃取物能提升皮膚細胞之粒線體活性以及多種抗老化基因之表現,進而維持皮膚細胞的活力及個體皮膚的年輕狀態。因此,本發明提供西番蓮花萃取物用於製備促進皮膚細胞粒線體活性或抗老化基因表現之組合物之用途。該組合物可為粉末狀、顆粒狀、液狀、膠狀或膏狀,且可製成食品、飲品、營養補充劑、或醫藥品,藉由口服、皮膚塗抹等方式給予一個體。 In summary, Passiflora extract can enhance the mitochondrial activity of skin cells and the performance of a variety of anti-aging genes, thereby maintaining the vitality of skin cells and the youthful state of the individual's skin. Therefore, the present invention provides the use of Passiflora extract for preparing a composition that promotes mitochondrial activity of skin cells or anti-aging gene expression. The composition can be in the form of powder, granules, liquid, gel or paste, and can be made into foods, drinks, nutritional supplements, or medicines, and can be administered to a body by oral administration, skin application and other methods.
<110> 大江生醫股份有限公司 <110> Dajiang Biomedical Co., Ltd.
<120> 西番蓮花萃取物用於促進皮膚細胞粒線體活性及抗老化基因表現之用途 <120> Passionflower extract is used to promote mitochondrial activity of skin cells and the expression of anti-aging genes
<130> 107B0594-I1 <130> 107B0594-I1
<160> 20 <160> 20
<170> PatentIn version 3.5 <170> PatentIn version 3.5
<210> 1 <210> 1
<211> 19 <211> 19
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 1 <400> 1
<210> 2 <210> 2
<211> 21 <211> 21
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 2 <400> 2
<210> 3 <210> 3
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 3 <400> 3
<210> 4 <210> 4
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 4 <400> 4
<210> 5 <210> 5
<211> 22 <211> 22
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 5 <400> 5
<210> 6 <210> 6
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 6 <400> 6
<210> 7 <210> 7
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 7 <400> 7
<210> 8 <210> 8
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 8 <400> 8
<210> 9 <210> 9
<211> 23 <211> 23
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 9 <400> 9
<210> 10 <210> 10
<211> 23 <211> 23
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 10 <400> 10
<210> 11 <210> 11
<211> 21 <211> 21
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 11 <400> 11
<210> 12 <210> 12
<211> 22 <211> 22
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 12 <400> 12
<210> 13 <210> 13
<211> 23 <211> 23
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 13 <400> 13
<210> 14 <210> 14
<211> 22 <211> 22
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 14 <400> 14
<210> 15 <210> 15
<211> 19 <211> 19
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 15 <400> 15
<210> 16 <210> 16
<211> 21 <211> 21
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 16 <400> 16
<210> 17 <210> 17
<211> 18 <211> 18
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 17 <400> 17
<210> 18 <210> 18
<211> 21 <211> 21
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 18 <400> 18
<210> 19 <210> 19
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 19 <400> 19
<210> 20 <210> 20
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> PCR引子 <223> PCR primer
<400> 20 <400> 20
Claims (5)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW108107295A TWI736855B (en) | 2019-03-05 | 2019-03-05 | Use of passiflora flower extracts for enhancing mitochondrial activity and anti-aging gene expression in skin cells |
| CN201910342301.5A CN111658682A (en) | 2019-03-05 | 2019-04-25 | Application of passionflower flower extract in promoting skin cell mitochondrion activity and anti-aging gene expression |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW108107295A TWI736855B (en) | 2019-03-05 | 2019-03-05 | Use of passiflora flower extracts for enhancing mitochondrial activity and anti-aging gene expression in skin cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202033207A TW202033207A (en) | 2020-09-16 |
| TWI736855B true TWI736855B (en) | 2021-08-21 |
Family
ID=72382260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW108107295A TWI736855B (en) | 2019-03-05 | 2019-03-05 | Use of passiflora flower extracts for enhancing mitochondrial activity and anti-aging gene expression in skin cells |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN111658682A (en) |
| TW (1) | TWI736855B (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002332224A (en) * | 2001-03-06 | 2002-11-22 | Kose Corp | Anti-ageing skin care preparation and anti-ageing skin care preparation composition |
| FR2931070B1 (en) * | 2008-05-13 | 2010-07-30 | Nuxe Lab | ASSOCIATION OF PASSIFLORE EXTRACTS AND ANCHUSES USED IN COSMETICS |
| FR2974298B1 (en) * | 2011-04-20 | 2013-11-29 | Nuxe Lab | VEGETABLE EXTRACT COMPLEX FOR SKIN PROTECTION |
| EP3291825A4 (en) * | 2015-05-05 | 2019-04-17 | Idunn Technologies | ANTI-AGING COMPOSITION COMPRISING A PLANT EXTRACT |
-
2019
- 2019-03-05 TW TW108107295A patent/TWI736855B/en active
- 2019-04-25 CN CN201910342301.5A patent/CN111658682A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN111658682A (en) | 2020-09-15 |
| TW202033207A (en) | 2020-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105164269A (en) | Compounds, compositions, methods and kits related to telomere extension | |
| US8945532B2 (en) | Anti-aging formulations | |
| JP2021176855A (en) | Composition for protein l-isoaspartate methyltransferase activation | |
| US20120225141A1 (en) | Substance for restoring normal co-expression and interaction between the lox and nrage proteins | |
| Wu et al. | Phytic acid promotes high glucose-mediated bone marrow mesenchymal stem cells osteogenesis via modulating circEIF4B that sponges miR-186-5p and complexes with IGF2BP3 | |
| Millan‐Linares et al. | GPETAFLR, a biopeptide from Lupinus angustifolius L., protects against oxidative and inflammatory damage in retinal pigment epithelium cells | |
| TW202103683A (en) | Halobacillus trueperitci66207 strain and its breaking liquid and use of the breaking liquid | |
| CN110151848A (en) | Orange peel fermented product and its preparation method and application | |
| CN110710682A (en) | Use of buckwheat seed coat extract to enhance mitochondrial activity, promote expression of anti-aging genes, and inhibit protein glycation | |
| Liu et al. | Epigallocatechin-3-gallate protects against tumor necrosis factor alpha induced inhibition of osteogenesis of mesenchymal stem cells | |
| TWI736855B (en) | Use of passiflora flower extracts for enhancing mitochondrial activity and anti-aging gene expression in skin cells | |
| CN116251126A (en) | Application of exosomes derived from periodontal ligament stem cells in alleviating cellular aging and treating periodontitis | |
| CN112823782B (en) | Use of plant juice for increasing expression level of anti-aging gene in cardiovascular cells | |
| TW202003587A (en) | Use of collagen peptide for inducing expression of CCT gene, Parkin gene and MRPS5 gene, enhancing mitochondrial activity of cells, promoting skin fibroblast proliferation, and anti-aging | |
| CN107613960A (en) | Cosmetic use of extracts derived from plant cell cultures enriched in somatic embryos and cosmetic compositions containing these extracts | |
| Zhao et al. | Lutein shows a protective effect against the aging of mesenchymal stem cells by downregulating inflammation | |
| CN110734869B (en) | Probiotic strain for delaying aging, composition and application thereof | |
| Kim et al. | Gold Kiwi-Derived Nanovesicles Mitigate Ultraviolet-Induced Photoaging and Enhance Osteogenic Differentiation in Bone Marrow Mesenchymal Stem Cells | |
| TWI734032B (en) | Use of tartary buckwheat husk extracts for improving mitochondrial activity | |
| Askari et al. | Anti-aging effects of the pistachio extract on mesenchymal stem cells proliferation and telomerase activity | |
| CN115154577A (en) | Application of Traditional Chinese Medicine Compositions Containing Ginseng, Licorice and Polygonatum | |
| JP2024016417A (en) | Pharmaceutical composition for promoting hyaluronic acid synthesis, and method for producing a pharmaceutical composition for promoting hyaluronic acid synthesis containing pomegranate seed extract | |
| Akbarizare et al. | Bilateral telomerase-associated impacts of Spirulina platensis extracts: activation versus inhibition | |
| TWI734058B (en) | Use of chimonanthus salicifolius extract for delaying skin cell aging | |
| JP6781925B1 (en) | Mineral metabolism disorder inhibitor |